Paid Clinical Trials in Beverly Hills, CA
As of August 2026, 162 paid clinical trials are recruiting in Beverly Hills, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Beverly Hills offers studies at sites including Tower Cancer Research Foundation for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Breast Cancer, Multiple Myeloma, Non Small Cell Lung Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Beverly Hills
Trials by drug in Beverly Hills
Filter results
Newly added in Beverly Hills
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
146 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Pelacarsen Roll-over Extension Program
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Top Research Study Locations in Beverly Hills
Researchers run research studies in Beverly Hills, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Tower Cancer Research Foundation | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma | 26 |
| Beverly Hills Cancer Center | Metastatic Breast Cancer, Breast Cancer, Non Small Cell Lung Cancer | 15 |
| National Heart Institute | Heart Failure, Aortic Stenosis, Atherosclerosis | 13 |
| Retina-Vitreous Associates Medical Group | Geographic Atrophy, Diabetic Macular Edema, Age - Related Macular Degeneration (AMD) | 10 |
| Cedars-Sinai Medical Center | Obesity or Overweight, ATTR Amyloidosis Wild Type, ATTR Gene Mutation | 8 |
| Precision NextGen Oncology | Advanced Cancer, Brain Metastases, Adult, Cervical Cancer | 4 |
| Precision NextGen Oncology & Research Center | Advanced Solid Tumors, CNS Tumor, Cancer | 4 |
| Precision NextGen Oncology and Research Center | Adenocarcinoma of Lung, Advanced Lung Cancer, Carcinoma, Non-Small-Cell Lung | 4 |
| Cardiovascular Research Foundation of Southern California | ASCVD, ASCVD Management, Atherosclerosis | 3 |
| Cedars-Sinai Cancer Beverly Hills | Breast Cancer, Breast Cancer Metastatic, Breast Neoplasm | 3 |
| Retina Vitreous Associates Medical Group | Age-related Macular Degeneration (AMD), DME, Diabetic Macular Edema | 3 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer | 2 |
| Attune Health Research Inc | RA - Rheumatoid Arthritis, SLE (Systemic Lupus), Telemedicine | 2 |
| Cardiovascular Res Found | Aortic Stenosis, Cardiovascular Disease and Lipoprotein(a) | 2 |
| Cedars-Sinai Cancer at Beverly Hills (THO) | Carcinoma, Lung Cancer, Non Small Cell Lung Cancer | 2 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 2 |
| Pacific Oaks Medical Group | HIV Infections, Percutaneous Coronary Intervention, Peripheral Endovascular Intervention | 2 |
| R3 Anti Aging Beverly Hills | Low Back Pain, Osteoarthritis, Knee | 2 |
| UCLA Health Beverly Hills Primary & Specialty Care | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | 2 |
| Wallace Rheumatic Study Center | Primary Sjogren's Disease, Systemic Lupus Erythematosus (SLE) | 2 |
| ADARx Clinical Site | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Amicis Research Center - Beverly Hills | Difficult to Control Hypertension | 1 |
| Amicis Research: Beverly Hills | Diabetes Mellitus, Type 2, Metabolic Syndrome, PreDiabetes | 1 |
| Attune Health Research, Inc | Active Idiopathic Inflammatory Myopathy, Antisynthetase Syndrome, Dermatomyositis | 1 |
Active & Upcoming Studies in Beverly Hills (2026)
Recruiting trials in Beverly Hills grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (73 active studies)
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · Phase 3 · National Cancer Institute (NCI)
- Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer · Phase 2 · Yuan Yuan
Eye & vision (13 active studies)
- A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study · Phase 3 · YS Life Science Co., Ltd.
- Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration · Phase 1, Phase 2 · Eyconis INC.
Cardiovascular (12 active studies)
- A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study · Phase 3 · YS Life Science Co., Ltd.
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Diabetes & metabolic (6 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
HIV / STI (2 active studies)
Neurology & pain (2 active studies)
Common conditions studied in Beverly Hills
- Anatomic Stage II Breast Cancer AJCC v8 (7 active studies)
- Breast Cancer (6 active studies)
- Multiple Myeloma (5 active studies)
- Non Small Cell Lung Cancer (5 active studies)
- Geographic Atrophy (4 active studies)
- Metastatic Breast Cancer (4 active studies)
Leading research sponsors in Beverly Hills
- National Cancer Institute (NCI)
- AstraZeneca
- SWOG Cancer Research Network
- AbbVie
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Beverly Hills?
There are approximately 162 recruiting clinical trials in Beverly Hills, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Beverly Hills pay participants?
Most recruiting trials in Beverly Hills compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Beverly Hills?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Beverly Hills?
The most common conditions under active study in Beverly Hills include Anatomic Stage II Breast Cancer AJCC v8 (7), Breast Cancer (6), Multiple Myeloma (5), Non Small Cell Lung Cancer (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Beverly Hills?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Beverly Hills on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Beverly Hills?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Beverly Hills?
Recruiting research sites in Beverly Hills include Tower Cancer Research Foundation, Beverly Hills Cancer Center, National Heart Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Beverly Hills right now?
The largest active categories in Beverly Hills are Cancer & tumors (73), Eye & vision (13), Cardiovascular (12). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.